Newsfeeds - Spark Newswire

2 minute read

Analyzing Bio-Path Holdings’s Short Interest

Today, 1:44 PM

Bio-Path Holdings's (NASDAQ:BPTH) short percent of float has fallen 10.42% since its last report. The company recently reported that it has 34 thousand shares sold short, which is 0.43% of all regular shares that are available for trading.

BPTH

10 minute read

News
Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 1:44 PM

During Tuesday's trading, 160 companies set new 52-week lows.

ABSI

2 minute read

Bio-Path Holdings Announces First Patient Dosed In Phase 1/1b Study Of BP1002 In Refractory/Relapsed Acute Myeloid Leukemia Patients

By Benzinga Newsdesk

Today, 1:44 PM

Bio-Path Holdings, Inc., (NASDAQ:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today

BPTH

3 minute read

Earnings Scheduled For August 16, 2022

By Benzinga Insights

Today, 1:44 PM

Companies Reporting Before The Bell • Stronghold Digital Mining (NASDAQ:SDIG) is projected to report earnings for its second quarter.

1 minute read

10 Biggest Price Target Changes For Thursday

By Lisa Levin

Today, 1:44 PM

Telsey Advisory Group cut the price target for Bath & Body Works, Inc. (NYSE: BBWI) from $70 to $60. Bath & Body Works shares fell 6.9% to $40.00 in pre-market trading.

AAPL

4 minute read

The Daily Biotech Pulse: Pfizer-BioNTech’s COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio’s AP-013 Trial Under Independent Investigation

By Vandana Singh

Today, 1:44 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ABEO

1 minute read

Bio-Path Holdings: Q1 Earnings Insights

By Benzinga Insights

Today, 1:44 PM

Bio-Path Holdings (NASDAQ:BPTH) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

BPTH